On August 28, Everpure fell 5.02% in regular trading, trading at $94.30/share with turnover of $115 million, extending the prior session's profit-taking and declining approximately 18% from its post-earnings high of $114.94.

On the news front, the company reported FY2027 Q2 results on August 26 after market close that significantly exceeded expectations: adjusted EPS of $0.70 beat the consensus estimate of $0.58 by 20.69%, representing 62.79% year-over-year growth; revenue of $1.186 billion materially surpassed the $1.097 billion estimate. The company also raised full-year revenue guidance to $5.03-5.07 billion, well above the Street's $4.50 billion forecast, with Q3 revenue guided to $1.325-1.335 billion versus estimates of $1.135 billion.

Despite the strong results, the stock had rallied sharply ahead of earnings and spiked to $114.94 in after-hours trading, triggering sustained profit-taking. Notably, BofA upgraded to Buy with a $150 target, and Wedbush raised its target to $130, calling the updated guidance still very beatable given continued system pricing strength.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)